NovaBridge Biosciences to Participate in Upcoming Investor Conferences
NovaBridge Biosciences NBP
$0.87
▼ -4.14%
($-0.04)
🧊 52W Low
⬇️ Below Yest. Low
📅 Earnings This Week
Open
$0.92
Prev Close
$0.91
Day Range
$0.86 – $0.92
52W Range
$0.88 – $5.19
Market Cap
$105.42M
Beta
1.79
EPS (TTM)
$-0.19
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-01-17 |
| Shares Out. | 270,740,000 |
| Website | novabridge.com/ ↗ |
| Phone | 13016702800 |
| Employees | 30 |
| Net Income | -$46.3M |
| Total Assets | $260.5M |
| Total Liabilities | $29.6M |
| Equity | $230.9M |
About NovaBridge Biosciences
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
NovaBridge Biosciences is a publicly traded company under the ticker symbol NBP on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2026-11-01)